Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Bleeding
Conditions
Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures, Prothrombin Complex Concentrates, Fresh Frozen Plasma
Trial Timeline
Aug 1, 2016 → Jan 1, 2022
NCT ID
NCT02557672About Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)
Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP) is a approved stage product being developed by CSL for Bleeding. The current trial status is completed. This product is registered under clinical trial identifier NCT02557672. Target conditions include Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02557672 | Approved | Completed |
Competing Products
20 competing products in Bleeding